This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignee: Glaxosmithkline Intellectual Property (No.3) Limited. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Karine Villeneuve: Innovator in Pharmaceutical Research
Introduction
Karine Villeneuve is a notable inventor based in Kirkland, CA. She has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target specific receptors involved in various diseases.
Latest Patents
Karine Villeneuve holds a patent titled "Indole Derivatives As Crth2 Receptor Antagonists." This patent describes compounds that act as antagonists of the PGD2 receptor, CRTH2, which are useful in the treatment and prevention of CRTH2-mediated diseases such as asthma. Despite having no patents listed under her name, her work in this area is noteworthy.
Career Highlights
Throughout her career, Karine has worked with prominent companies in the pharmaceutical industry, including Merck Canada Inc. and Merck Sharp & Dohme Corporation. Her experience in these organizations has allowed her to contribute to significant advancements in drug development.
Collaborations
Karine has collaborated with esteemed colleagues such as Carl Berthelette and Michael Boyd. These partnerships have enhanced her research and innovation efforts in the pharmaceutical sector.
Conclusion
Karine Villeneuve is a dedicated inventor whose work in pharmaceutical research has the potential to impact the treatment of various diseases. Her contributions, particularly in receptor antagonism, highlight her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile